Back to Search
Start Over
Polycystic ovary syndrome (PCOS).
- Source :
- Diabetes & Primary Care; 2023, Vol. 25 Issue 6, p189-191, 3p
- Publication Year :
- 2023
-
Abstract
- Polycystic ovary syndrome (PCOS) is the most common endocrine disorder in women of reproductive age. Characterised by insulin resistance and hyperinsulinaemia, it is associated with increased risk of cardiovascular and cerebrovascular events, type 2 diabetes and impaired glucose tolerance. It is further linked to pregnancy-related complications, including gestational diabetes and venous thromboembolism. The disease is distinguished by the presence and degree of three major features: irregular menstruation, hyperandrogenism, and polycystic ovarian morphology (including increased follicle numbers and enlarged ovaries). PCOS is a life-long problem. However, the symptoms can be successfully managed with proper medication and lifestyle interventions. [ABSTRACT FROM AUTHOR]
- Subjects :
- POLYCYSTIC ovary syndrome treatment
THERAPEUTIC use of progestational hormones
CARDIOVASCULAR diseases risk factors
GLUCOSE intolerance
HYPERTENSION
POLYCYSTIC ovary syndrome
CEREBROVASCULAR disease
VEINS
TYPE 2 diabetes
HYPERLIPIDEMIA
INFERTILITY
MEDICAL protocols
MEDICAL referrals
PREGNANCY complications
THROMBOEMBOLISM
ENDOMETRIAL tumors
SLEEP apnea syndromes
ORAL contraceptives
WEIGHT loss
GESTATIONAL diabetes
PATIENT education
METFORMIN
DISEASE management
HEALTH promotion
DISEASE risk factors
SYMPTOMS
DISEASE complications
Subjects
Details
- Language :
- English
- ISSN :
- 14668955
- Volume :
- 25
- Issue :
- 6
- Database :
- Complementary Index
- Journal :
- Diabetes & Primary Care
- Publication Type :
- Academic Journal
- Accession number :
- 175422395